Mechanisms of blood flow-induced vascular enlargement

Biorheology

Volumn 39, Issue 3-4, 2002, Pages 319-324

  Lehoux, Stéphanie ^a   Tronc, François ^a   Tedgui, Alain ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Growth factors; Matrix metalloproteinases; Nitric oxide; Shear stress

Indexed keywords

GROWTH FACTOR; MATRIX METALLOPROTEINASE; NITRIC OXIDE;

BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FLOW KINETICS; NONHUMAN; SHEAR STRESS; VASCULAR ENDOTHELIUM;

ANIMALS; AORTIC ANEURYSM; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HUMANS; MATRIX METALLOPROTEINASES; NITRIC OXIDE; REGIONAL BLOOD FLOW; RHEOLOGY; STRESS, MECHANICAL; VASODILATION;

EID: 0036373877     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model
2. Vascular relaxation and cyclic guanosine monophosphate in a rat model of high output heart failure
3. Arterial expansive remodeling induced by high flow rates
4. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease
5. Fluid flow stimulates metalloproteinase production and deposition into the extracellular matrix of endothelial cells
6. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
7. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion
8. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
9. Compensatory enlargement of human atherosclerotic coronary arteries
10. Is intimal hyperplasia an adaptative response or a pathologic process? Observations on the nature of nonatherosclerotic intimal thickening
11. Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms
12. Scanning electron microscopic investigation of the afferent arteries of experimental femoral arteriovenous fistulae in rabbits
13. Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter
14. Flow-induced arterial enlargement is inhibited by suppression of nitric oxide synthase activity in vivo
15. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
16. Nitric oxide selectively amplifies FGF-2 induced mitogenesis in primary rat aortic smooth muscle cells
17. Reactive dilatation of large coronary arteries in conscious dogs
18. Flow-dependent, endothelium-mediated dilatation of epicardial coronary arteries in conscious dogs: Effects of cyclooxygenase inhibition
19. Shear-induced platelet-derived growth factor gene expression in human endothelial cells is mediated by protein kinase-C
20. The ultrastructure of arteries proximal to chronic experimental carotid-jugular fistulae in rabbits
21. Ultrastructural changes in arteries proximal to short-term experimental carotid-jugular arteriovenous fistulae in rabbits
22. Adaptive regulation of wall shear stress to flow change in the canine carotid artery
23. Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456
24. Interaction of pressure-induced and flow-induced responses in porcine coronary resistance vessels
25. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent
26. Mechanism of enlargement of major cerebral arteries in rabbits
27. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
28. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor-B chain in vascular endothelium
29. Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement
30. Modulation of NO and endothelin by chronic increases in blood flow in canine femoral arteries
31. The mechanism of the development of collateral circulation
32. Nitric oxide activates metalloprotase enzymes in articular cartilage
33. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagen, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity
34. Crucial role of endothelium in the vasodilatator response to increased flow in vivo
35. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability
36. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase
37. Vascular caliber
38. Flow-induced release of endothelium-derived relaxing factor
39. Aneurysm development and degenerative changes in dilated artery proximal to arterionenous fistula
40. Basic fibroblast growth factor expression precedes flow-induced arterial enlargement
41. Chronic changes in experimental saccular and fusiform aneurysms in rabbits
42. Difference in dilatation between endothelium-preserved and -desquamated segments in the flow-loaded rat common carotid artery
43. Role of matrix metalloproteinases in blood flow-induced arterial enlargement
44. Role of NO in flow-induced remodeling of the rabbit common carotid artery
45. Developmental remodeling of the internal elastic lamina of rabbit arteries - Effect of blood flow
46. Shear stress regulation of artery lumen diameter in experimental atherogenosis
47. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor
48. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF